FNTB Gene (Farnesyltransferase, CAAX Box, Beta Subunit)

A key enzyme in protein prenylation, implicated in cancer and progeria syndromes.

Gene Information Card

Symbol FNTB
Full Name Farnesyltransferase, CAAX Box, Beta Subunit
Gene Type Protein coding
Chromosomal Location 14q23.3
NCBI Gene ID 2342 ncbi.nlm.nih.gov/gene/2342
Ensembl ID ENSG00000100804
UniProt ID P49356
OMIM ID 134635
HGNC ID 3785
Aliases FTase-beta, FPTB, PTAR2

Description

The FNTB gene encodes the beta subunit of farnesyltransferase, a heterodimeric enzyme that catalyzes the addition of a farnesyl group to the cysteine residue of CAAX motif-containing proteins. This prenylation is essential for the membrane localization and function of many proteins, including members of the RAS superfamily. FNTB is a target for anticancer drug development, particularly in RAS-driven tumors.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hutchinson-Gilford Progeria Syndrome Mutations in LMNA produce a permanently farnesylated prelamin A; FNTB inhibition reduces progerin toxicity. ClinVar, OMIM
Various Cancers (e.g., lung, pancreatic, colon) Overexpression or altered splicing of FNTB enhances farnesylation of oncogenic RAS, promoting tumor growth. COSMIC, NCBI Gene
Myelodysplastic Syndrome FNTB mutations or copy number alterations may contribute to dysregulated prenylation in hematopoietic cells. COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.5 Medium
Adrenal Gland 9.8 Medium
Pancreas 8.2 Medium
Liver 6.1 Low
Brain 4.3 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa (cervical carcinoma) 10.2 High expression
A549 (lung carcinoma) 9.5 High expression
MCF7 (breast carcinoma) 7.8 Medium expression
K562 (leukemia) 6.4 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1096G>A (p.Gly366Arg) Missense <0.1% Altered substrate binding affinity
c.1243C>T (p.Arg415Trp) Missense <0.1% Potential loss of catalytic activity
c.1472_1473insA Frameshift <0.1% Truncated protein, likely loss of function
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations that produce truncated or unstable FNTB protein, reducing farnesyltransferase activity.

Gain of Function (GOF)

Not well documented; some missense variants may increase catalytic efficiency but are rare.

Dominant Negative (DN)

Not reported for FNTB.

Pathways

Protein Prenylation (R-HSA-8873719)
Signaling by RAS mutants (R-HSA-6802949)
Farnesylation of RAS (R-HSA-9649945)

Protein Summary

FNTB encodes the 437-amino-acid beta subunit of farnesyltransferase. The enzyme is a zinc metalloprotein that, together with the alpha subunit (FNTA), transfers a farnesyl moiety from farnesyl diphosphate to the cysteine of CAAX motifs. The beta subunit determines substrate specificity. FNTB is ubiquitously expressed with highest levels in testis and adrenal gland. Inhibition of FNTB is a therapeutic strategy for progeria and RAS-mutant cancers.

Related Products

Product name Cat.No. Species Gene ID
CHURC1-FNTB Knockout HEK293 Cell Line EDJ-KQ52500 Human 100529261 Details Get a Quote
CHURC1-FNTB Knockout HeLa Cell Line EDJ-KQ60963 Human 100529261 Details Get a Quote
CHURC1-FNTB Knockout A-549 Cell Line EDJ-KQ69438 Human 100529261 Details Get a Quote
CHURC1-FNTB Knockout HCT 116 Cell Line EDJ-KQ77789 Human 100529261 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: